Kiniksa Pharmaceuticals International, plc KNSA Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Based on trailing twelve months.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's return on equity?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported return on equity of 13.7% in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's return on equity changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's return on equity increased by 460.6% year-over-year, from -3.8% to 13.7%.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's return on equity?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's return on equity has grown at a -27.9% compound annual growth rate (CAGR), from -60.1% to 11.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.